Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has...
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
ARYA Sciences Acquisition Corp IV’s Acquisition of Amicus Therapeutics’ Gene Therapy Business
Skadden, Arps, Slate, Meagher & Flom, Wilson Sonsini Goodrich & Rosati and Troutman Pepper Hamilton Sanders represented Amicus Therapeutics, while Kirkland & Ellis represented ARYA IV...


























